Product Information
TIZANIDINE HCL 2 MG CAPSULE is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.0830 per EA under NDC 75834020715. Its NADAC has been published 268 times since Jan 22, 2020.
FDA first approved this application on Mar 26, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the TIZANIDINE HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834020715
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
TIZANIDINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210021FDA Approved
3/26/2019
TE Code
AB
On Market Since
9/26/2019
Pharmacological Classes
Price Statistics
The NADAC for TIZANIDINE HCL 2 MG CAPSULE has been published 268 times since Jan 22, 2020, and over the history we have for it it has declined 83.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0830 per EA |
|---|---|
| All-time high | $0.4993 (Feb 12, 2020) |
| All-time low | $0.0693 (May 17, 2023) |
| Median price | $0.1064 |
| Average price | $0.1346 |
| Largest weekly change | +60.8% (Jul 22, 2020) |
| Weeks tracked | 268 |
| Tracking since | Jan 22, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-23.6%
5Y
-46.0%
All
-83.4%
Last surveyed Mar 5, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the TIZANIDINE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TIZANIDINE HCL 2 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TIZANIDINE HCL 2 MG CAPSULE, manufactured by Nivagen Pharmaceuticals Inc., is $0.0830 per EA (NDC 75834020715), effective Mar 5, 2025.
How has the price of TIZANIDINE HCL 2 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TIZANIDINE HCL 2 MG CAPSULE has declined 83.4%. It has been tracked across 268 weekly CMS publications since Jan 22, 2020.
What are the highest and lowest recorded NADAC prices for TIZANIDINE HCL 2 MG CAPSULE?
Since Jan 22, 2020, the NADAC for TIZANIDINE HCL 2 MG CAPSULE has ranged from a low of $0.0693 (May 17, 2023) to a high of $0.4993 (Feb 12, 2020), with a median of $0.1064 per EA.
Are there cheaper alternatives to TIZANIDINE HCL 2 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of TIZANIDINE HCL 2 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TIZANIDINE HCL 2 MG CAPSULE?
TIZANIDINE HCL 2 MG CAPSULE (NDC 75834020715) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.